Skip to content

BlueRun Ventures China

Request correction

Corporate brand

Unclaimed

BlueRun Ventures China (蓝驰创投) is a China-focused early-stage venture capital firm investing in technology, consumer and healthcare startups.

Last updated October 30, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

BlueRun Ventures China (蓝驰创投) is the China-focused venture capital arm of the BlueRun Ventures franchise, an early-stage investor that backs founders in technology, consumer internet, enterprise software, fintech, healthcare and hard-tech sectors. The firm operates as a private, partner-owned investment house rather than a listed company, and its brand is built on early-stage (seed to Series A/B) conviction investing in Chinese startups. The supplied evidence for this entry does not contain substantive material about BlueRun Ventures China itself; the retrieved pages are unrelated Sina Finance research-report listings covering other companies. As a result, this dossier is deliberately conservative: it records the firm's identity as a venture capital brand, its China market focus and its private ownership status, while omitting unverified specifics such as founding year, founding partners, fund sizes, portfolio names and office addresses. BlueRun's positioning in the Chinese market is that of a long-cycle, thesis-driven early investor that works closely with founders from the earliest stages and supports them through subsequent financing rounds. Its brand is associated with technology-driven venture investing rather than with consumer product manufacturing or retail. Because the evidence base is thin, readers should treat this entry as an identity-level record and consult the firm's official channels for authoritative details on funds, partners and portfolio.

History

BlueRun Ventures China (蓝驰创投) is the China-focused venture capital practice operating under the BlueRun Ventures name, an early-stage investment franchise. The firm invests in founders building technology-driven companies in China, typically entering at seed or early venture rounds and reserving capital for follow-on support. No reliable, evidence-backed chronology of the firm's founding, fund generations, partner transitions or notable portfolio outcomes was available in the supplied material, so this history section intentionally avoids dated claims. The retrieved pages were Sina Finance research-report indexes covering unrelated listed companies and contain no information about BlueRun Ventures China. What can be stated at the identity level is that the firm operates as a private, partner-owned venture capital brand rather than a listed or state-owned entity, and that its market is China. Its brand equity rests on early-stage deal access, founder relationships and sector theses in technology and adjacent growth areas. For a full corporate history — founding year, founding partners, fund sizes, portfolio companies and exits — the firm's official website and regulatory filings should be consulted; those details are omitted here rather than estimated.

Products and positioning

Thesis-driven early-stage venture capital investor focused on the China market.

  • Early-stage venture capital funds

    Pooled investment vehicles making seed and early-stage equity investments in Chinese startups.

Recent events

  • Weijiu Optoelectronics completes nearly RMB 100 million funding round[2]

    Weijiu Optoelectronics announced on August 24 that it completed a new funding round of nearly RMB 100 million, with participation from Xinhe Capital, Peng Qian, Appotronics, and the Beijing Economic-Technological Development Area Seed Investment Fund, alongside follow-on investment from existing shareholders Qiancheng Capital and BlueRun Ventures.

  • Reported

    20n Bio raises $3.3 million seed round[3]

    20n Bio raised $3.3 million in a seed round led by BlueRun Ventures China. The company said it would use the financing to expand its scientific team, establish a discovery platform, and start early studies.

  • Reported

    Anxin Wangdun completes Series A funding[4]

    Anxin Wangdun announced that it had completed a Series A financing of more than RMB 100 million, led by Hillhouse Venture Capital, with participation from Yunhui Capital and China Merchants Venture, and follow-on investment from existing investor Lightspeed China Partners.

  • Reported

    百图生科 completes Series A funding of over US$100 million[5]

    百图生科 announced that it had completed Series A funding of over US$100 million. GGV Capital led the round, with Baidu, Legend Capital, BlueRun Ventures, ZhenFund and Xiang He Capital participating; the proceeds are mainly for technology research and development and talent recruitment.

  • Reported

    芯来科技 completed a new funding round[6]

    芯来科技 announced that it had completed a new funding round led by Legend Capital, with several other funds participating and existing investors also investing further. The article says the round brought its funding across three rounds in one year to several hundred million yuan cumulatively.

  • Reported

    Thinkenergy completes pre-Series A funding round[7]

    Thinkenergy announced that it had completed a pre-Series A funding round worth tens of millions of yuan, led by BlueRun Ventures with participation from existing shareholder Chuangjian Capital. The funds are primarily intended to advance product research and development and commercial deployment.

  • Reported

    宜买车 completes $70 million Series C funding round[8]

    宜买车 announced that it completed a $70 million Series C funding round led by SIG, with existing shareholders also participating. The funds are mainly intended for building its consumer digitization system and further developing supply-chain digitization.

  • Unconfirmed

    Reported

    Tang Jihhede completes A+ funding round[9]

    Tang Jihhede announced that it had completed an A+ funding round worth tens of millions, with BlueRun Ventures as the sole investor. It said the funds would mainly support product research and development upgrades, market expansion, and building its delivery and supply-chain systems.

  • Unconfirmed

    Reported

    Aiwuguan completes Pre-Series A funding[10]

    Aiwuguan announced that it had completed a Pre-Series A funding round worth tens of millions of yuan, with BlueRun Ventures as the sole investor. The funds are to be used for business scaling and core technology optimization and iteration.

  • Reported

    NOLO VR completes $20 million Series B funding[11]

    NOLO VR completed a $20 million Series B funding round led by NIO Capital, with existing investors BlueRun Ventures and Joy Capital also participating. The proceeds will fund next-generation interaction technology research and development, new-product mass production, and content ecosystem development.

Read more(13)

Sources16 sources

Cite this profile: Cite the canonical profile. /brand-wiki/蓝驰创投 · Editorial policy · How profiles are compiled